Relay Therapeutics, Inc. (RLAY)
17.88
+0.47
(+2.70%)
USD |
NASDAQ |
Oct 09, 16:00
17.88
0.00 (0.00%)
After-Hours: 17:35
Relay Therapeutics 30-Day Average Daily Volume : 3.418M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 3.418M |
| October 07, 2026 | 3.371M |
| October 06, 2026 | 3.348M |
| October 05, 2026 | 3.307M |
| October 02, 2026 | 3.308M |
| October 01, 2026 | 3.309M |
| September 30, 2026 | 3.284M |
| September 29, 2026 | 3.266M |
| September 28, 2026 | 3.207M |
| September 25, 2026 | 3.197M |
| September 24, 2026 | 3.157M |
| September 23, 2026 | 3.089M |
| September 22, 2026 | 2.997M |
| September 21, 2026 | 2.965M |
| September 18, 2026 | 2.942M |
| September 17, 2026 | 2.687M |
| September 16, 2026 | 2.634M |
| September 15, 2026 | 2.632M |
| September 14, 2026 | 2.594M |
| September 11, 2026 | 2.573M |
| September 10, 2026 | 2.497M |
| September 09, 2026 | 2.461M |
| September 08, 2026 | 2.357M |
| September 04, 2026 | 2.330M |
| September 03, 2026 | 2.329M |
| Date | Value |
|---|---|
| September 02, 2026 | 2.280M |
| September 01, 2026 | 2.254M |
| August 31, 2026 | 2.250M |
| August 28, 2026 | 2.240M |
| August 27, 2026 | 2.220M |
| August 26, 2026 | 2.260M |
| August 25, 2026 | 2.213M |
| August 24, 2026 | 2.179M |
| August 21, 2026 | 2.170M |
| August 20, 2026 | 2.177M |
| August 19, 2026 | 2.232M |
| August 18, 2026 | 2.305M |
| August 17, 2026 | 2.403M |
| August 14, 2026 | 2.446M |
| August 13, 2026 | 2.501M |
| August 12, 2026 | 2.553M |
| August 11, 2026 | 2.693M |
| August 10, 2026 | 2.768M |
| August 07, 2026 | 3.098M |
| August 06, 2026 | 3.260M |
| August 05, 2026 | 3.332M |
| August 04, 2026 | 3.462M |
| August 03, 2026 | 3.541M |
| July 31, 2026 | 3.845M |
| July 30, 2026 | 3.881M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| SELLAS Life Sciences Group, Inc. | 6.315M |
| Karyopharm Therapeutics, Inc. | 1.457M |
| Spyre Therapeutics, Inc. | 1.466M |
| Akebia Therapeutics, Inc. | 7.543M |
| ACADIA Pharmaceuticals, Inc. | 2.086M |